Chiral Hydroxy Metabolite of Mebendazole: Analytical and Semi-Preparative High-Performance Liquid Chromatography Resolution and Chiroptical Properties

Mebendazole (<b>MBZ</b>) is a benzimidazole carbamate anthelmintic used worldwide for the treatment and prevention of parasitic disorders in animals and humans. A large number of in vivo and in vitro studies have demonstrated that <b>MBZ</b> also has anticancer activity in mu...

Full description

Saved in:
Bibliographic Details
Main Authors: Paolo Guglielmi (Author), Gaia Pulitelli (Author), Francesca Arrighi (Author), Daniela Secci (Author), Marco Pierini (Author), Roberto Cirilli (Author)
Format: Book
Published: MDPI AG, 2024-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e2c8ed2168bb4c71a89749d93b5843c5
042 |a dc 
100 1 0 |a Paolo Guglielmi  |e author 
700 1 0 |a Gaia Pulitelli  |e author 
700 1 0 |a Francesca Arrighi  |e author 
700 1 0 |a Daniela Secci  |e author 
700 1 0 |a Marco Pierini  |e author 
700 1 0 |a Roberto Cirilli  |e author 
245 0 0 |a Chiral Hydroxy Metabolite of Mebendazole: Analytical and Semi-Preparative High-Performance Liquid Chromatography Resolution and Chiroptical Properties 
260 |b MDPI AG,   |c 2024-05-01T00:00:00Z. 
500 |a 10.3390/ph17060696 
500 |a 1424-8247 
520 |a Mebendazole (<b>MBZ</b>) is a benzimidazole carbamate anthelmintic used worldwide for the treatment and prevention of parasitic disorders in animals and humans. A large number of in vivo and in vitro studies have demonstrated that <b>MBZ</b> also has anticancer activity in multiple types of cancers. After oral administration, the phenylketone moiety of <b>MBZ</b> is rapidly reduced to the hydroxyl group to form the chiral hydroxy metabolite (<b>MBZ-OH</b>). To the best of our knowledge, there is no information in the literature on the stereochemical course of transformation and the anthelmintic and antitumor activity of individual enantiomers of <b>MBZ-OH</b>. In the present study, we describe in detail the direct HPLC resolution of <b>MBZ-OH</b> on a 100 mm × 4.6 mm Chirapak IG-3 column packed with 3 μm silica particles containing amylose (3-chloro-5-methylphenylcarbamate) as a selector. At 25 °C and using pure methanol as the mobile phase, the enantioseparation and resolution factors were 2.38 and 6.13, respectively. These conditions were scaled up at a semi-preparative scale using a 250 mm × 10 mm Chiralpak IG column to isolate multi-milligram amounts of both enantiomeric forms of the chiral metabolite. The chiroptical properties of the collected enantiomers were determined and, through a theoretical study, were related to the more stable conformations of MBZ-OH. The first and second eluted enantiomers were dextrorotatory and levorotatory, respectively, in dimethylformamide solution. Finally, by recording the retention factors of the enantiomers as the water content in the water-acetonitrile mobile phases was progressively varied, U-shaped retention maps were generated, indicating a dual and competitive hydrophilic interaction liquid chromatography and reversed-phase liquid chromatography retention mechanism on the Chirapak IG-3 chiral stationary phase. 
546 |a EN 
690 |a hydroxy mebendazole 
690 |a Chiralpak IG 
690 |a enantioselective HPLC 
690 |a chiroptical properties 
690 |a theoretical calculations 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 17, Iss 6, p 696 (2024) 
787 0 |n https://www.mdpi.com/1424-8247/17/6/696 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/e2c8ed2168bb4c71a89749d93b5843c5  |z Connect to this object online.